The AHA today submitted a letter to the Office of Science and Technology Policy in response to its request for information on regulatory reform for artificial intelligence, emphasizing the need to reduce regulatory burdens that hinder innovation and increase costs, while ensuring patient safety and data privacy. The letter outlines four key recommendations: synchronizing AI policies with existing frameworks to avoid redundancy, removing regulatory barriers such as fragmented privacy laws and outdated substance use disorder regulations, ensuring safe and effective AI use through clinician involvement in decision loops that impact care delivery and consistent standards for third-party vendors, and addressing organizational and infrastructural challenges by aligning incentives and investing in digital access and literacy. The AHA encourages OSTP to ensure balanced, flexible policies that support innovation and improve care delivery across the health system. 

Headline
The AHA Aug. 13 responded to a Food and Drug Administration request for input on the risks and benefits to health and safety associated with non-device…
Headline
The Common Health Coalition announced Aug. 13 that it will receive $100 million in funding from the OpenAI Foundation for a new initiative using artificial…
Headline
The AHA’s American Organization for Nursing Leadership will host a webinar Aug. 5 at noon ET on how nurse leaders can guide ambient documentation from pilot…
Headline
In this conversation, Ajay Gupta, board vice chair for Trinity Health Mid-Atlantic, explains how trustees can confidently guide artificial intelligence…
Headline
The Department of Health and Human Services July 22 announced that it will participate in the Genesis Mission, an artificial intelligence initiative focusing…
Headline
Edward You, former FBI Supervisory Special Agent and founder of EHY Consulting, explains why healthcare organizations must look beyond artificial intelligence…